Loss of RUNX3 Gene Expression in Stomach Cancer
Author Information
Author(s): Nakase Y, Sakakura C, Miyagawa K, Kin S, Fukuda K, Yanagisawa A, Koide K, Morofuji N, Hosokawa Y, Shimomura K, Katsura K, Hagiwara A, Yamagishi H, Ito K, Ito Y
Primary Institution: Department of Surgery and Physiology of Digestive System, Graduate School of Medical Science, Surgery and Regenerative Medicine, Kyoto, Japan
Hypothesis
The study aims to determine whether alteration of RUNX3 gene expression could be detected in normal-looking gastric remnant mucosa and to ascertain differences in gastric carcinogenesis potential between anastomotic and other areas.
Conclusion
The residual stomach mucosa of the RM group has a higher potential for gastric carcinogenesis compared to the RB or GCI groups.
Supporting Evidence
- RUNX3 downregulation was observed in 82.1% of RB cases and 85.7% of RM cases.
- Adjacent mucosa in RB and RM groups showed significantly higher RUNX3 downregulation compared to GCI group.
- Cancers in the RB group were predominantly located in the anastomosis area.
Takeaway
This study found that a gene called RUNX3 is less active in stomach cancer, especially in areas near where surgery was done, which might mean those areas are more likely to develop cancer.
Methodology
The study analyzed RUNX3 expression using in situ hybridization, quantitative RT-PCR, and methylation-specific PCR in gastric cancer patients.
Limitations
The study focused on specific patient groups and may not generalize to all gastric cancer patients.
Participant Demographics
Patients included 89 with gastric cancer from intact stomach and 58 with remnant gastric cancer, with a mix of genders and ages.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website